Other Species / Isoforms
  NCK1 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
Y13-p
VVVAKFDyVAQQEQE
0 1
NCK1 (human) VVVAKFDyVAQQEQE Y13-p
NCK1 iso2 (human) gap -
NCK1 (mouse) VVVAKFDYVAQQEQE Y13
NCK1 (rat) VVVAKFDYVAQQEQE Y13
Y55-p
TGFVPSNyVERKNsA
0 1
NCK1 (human) TGFVPSNyVERKNsA Y55-p
NCK1 iso2 (human) gap -
NCK1 (mouse) TGFVPSNYVERKNSA Y55
NCK1 (rat) TGFVPSNYVERKNSA Y55
S61-p
NyVERKNsARKAsIV
0 6
NCK1 (human) NyVERKNsARKAsIV S61-p
NCK1 iso2 (human) gap -
NCK1 (mouse) NYVERKNSARKAsIV S61
NCK1 (rat) NYVERKNSARKAsIV S61
S66-p
KNsARKAsIVkNLKD
0 8
NCK1 (human) KNsARKAsIVkNLKD S66-p
NCK1 iso2 (human) gap -
NCK1 (mouse) KNSARKAsIVKNLKD S66-p
NCK1 (rat) KNSARKAsIVKNLKD S66-p
K69-ub
ARKAsIVkNLKDtLG
0 1
NCK1 (human) ARKAsIVkNLKDtLG K69-ub
NCK1 iso2 (human) under review -
NCK1 (mouse) ARKAsIVKNLKDtLG K69
NCK1 (rat) ARKAsIVKNLKDTLG K69
T74-p
IVkNLKDtLGIGkVK
0 7
NCK1 (human) IVkNLKDtLGIGkVK T74-p
NCK1 iso2 (human) gap -
NCK1 (mouse) IVKNLKDtLGIGKVK T74-p
NCK1 (rat) IVKNLKDTLGIGKVK T74
K79-ub
KDtLGIGkVKRKPsV
0 1
NCK1 (human) KDtLGIGkVKRKPsV K79-ub
NCK1 iso2 (human) KDFFSIGKVKRKPsV K15
NCK1 (mouse) KDtLGIGKVKRKPsV K79
NCK1 (rat) KDTLGIGKVKRKPsV K79
S85-p
GkVKRKPsVPdsAsP
Upstream
0 443
Treatment
  • angiotensin_2
  • AZD1152
  • BI2536
  • EGF
  • ephrin_B1
  • LRRK2-IN-1
  • metastatic potential
  • MLN8054
  • SB202190
  • selumetinib
  • SII_angiotensin_2
  • U0126
  • vemurafenib
  • ZM447439
NCK1 (human) GkVKRKPsVPdsAsP S85-p
NCK1 iso2 (human) GKVKRKPsVPDSAsP S21-p
NCK1 (mouse) GKVKRKPsVPDtAsP S85-p
NCK1 (rat) GKVKRKPsVPDTAsP S85-p
D88-ca
KRKPsVPdsAsPADD
0 2
NCK1 (human) KRKPsVPdsAsPADD D88-ca
NCK1 iso2 (human) KRKPsVPDSAsPADD D24
NCK1 (mouse) KRKPsVPDtAsPADD D88
NCK1 (rat) KRKPsVPDTAsPADD D88
S89-p
RKPsVPdsAsPADDs
Upstream
0 42
Treatment
  • metastatic potential
NCK1 (human) RKPsVPdsAsPADDs S89-p
NCK1 iso2 (human) RKPsVPDSAsPADDS S25
NCK1 (mouse) RKPsVPDtAsPADDs T89-p
NCK1 (rat) RKPsVPDTAsPADDS T89
S91-p
PsVPdsAsPADDsFV
Upstream
0 29
Treatment
  • BI2536
  • BI_4834
  • metastatic potential
  • MLN8054
  • selumetinib
  • vemurafenib
NCK1 (human) PsVPdsAsPADDsFV S91-p
NCK1 iso2 (human) PsVPDSAsPADDSFV S27-p
NCK1 (mouse) PsVPDtAsPADDsFV S91-p
NCK1 (rat) PsVPDTAsPADDSFV S91-p
S96-p
sAsPADDsFVDPGER
Upstream
0 69
Treatment
  • AZD1152
  • BI_4834
  • nocodazole
  • ZM447439
NCK1 (human) sAsPADDsFVDPGER S96-p
NCK1 iso2 (human) SAsPADDSFVDPGER S32
NCK1 (mouse) tAsPADDsFVDPGER S96-p
NCK1 (rat) TAsPADDSFVDPGER S96
Y105-p
VDPGERLyDLNMPAy
Upstream
2 903
Kinase, in vitro:
  • Abl (human)
Putative in vivo kinases:
  • Abl (human)
Treatment
  • anti-CD3
  • ephrin_B1
  • ephrin_B2
  • erlotinib
  • nocodazole
  • Su11274
  • U0126
NCK1 (human) VDPGERLyDLNMPAy Y105-p
NCK1 iso2 (human) VDPGERLYDLNMPAY Y41
NCK1 (mouse) VDPGERLyDLNMPAF Y105-p
NCK1 (rat) VDPGERLyDLNMPAF Y105-p
Y112-p
yDLNMPAyVKFNYMA
Upstream
0 116
Treatment
  • ephrin_B1
  • imatinib
NCK1 (human) yDLNMPAyVKFNYMA Y112-p
NCK1 iso2 (human) YDLNMPAYVKFNYMA Y48
NCK1 (mouse) yDLNMPAFVKFNYMA F112
NCK1 (rat) yDLNMPAFVKFNYMA F112
K129-ub
EDELSLIkGTKVIVM
0 1
NCK1 (human) EDELSLIkGTKVIVM K129-ub
NCK1 iso2 (human) EDELSLIKGTKVIVM K65
NCK1 (mouse) EDELSLIKGTKVIVM K129
NCK1 (rat) EDELSLIKGTKVIVM K129
S147
SDGWWRGSYNGQVGW
0 1
NCK1 (human) SDGWWRGSYNGQVGW S147
NCK1 iso2 (human) SDGWWRGSYNGQVGW S83
NCK1 (mouse) SDGWWRGsyNGQIGW S147-p
NCK1 (rat) SDGWWRGSYNGQIGW S147
Y148
DGWWRGSYNGQVGWF
0 1
NCK1 (human) DGWWRGSYNGQVGWF Y148
NCK1 iso2 (human) DGWWRGSYNGQVGWF Y84
NCK1 (mouse) DGWWRGsyNGQIGWF Y148-p
NCK1 (rat) DGWWRGSYNGQIGWF Y148
Y159
VGWFPSNYVTEEGDs
0 1
NCK1 (human) VGWFPSNYVTEEGDs Y159
NCK1 iso2 (human) VGWFPSNYVTEEGDS Y95
NCK1 (mouse) IGWFPSNyVtEEGDs Y159-p
NCK1 (rat) IGWFPSNYVTEEGDs Y159
T161
WFPSNYVTEEGDsPL
0 1
NCK1 (human) WFPSNYVTEEGDsPL T161
NCK1 iso2 (human) WFPSNYVTEEGDSPL T97
NCK1 (mouse) WFPSNyVtEEGDsPL T161-p
NCK1 (rat) WFPSNYVTEEGDsPL T161
S166-p
YVTEEGDsPLGDHVG
0 18
NCK1 (human) YVTEEGDsPLGDHVG S166-p
NCK1 iso2 (human) YVTEEGDSPLGDHVG S102
NCK1 (mouse) yVtEEGDsPLGDHVG S166-p
NCK1 (rat) YVTEEGDsPLGDHVG S166-p
K178-ub
HVGSLSEkLAAVVNN
1 0
NCK1 (human) HVGSLSEkLAAVVNN K178-ub
NCK1 iso2 (human) HVGSLSEKLAAVVNN K114
NCK1 (mouse) HVGSLSEKLAAVVNN K178
NCK1 (rat) HVGSLSEKLAAVVNN K178
K231-ub
ENDPEWWkCRKINGM
0 1
NCK1 (human) ENDPEWWkCRKINGM K231-ub
NCK1 iso2 (human) ENDPEWWKCRKINGM K167
NCK1 (mouse) ENDPEWWKCRKINGM K231
NCK1 (rat) ENDPEWWKCRKINGM K231
S262-p
LTSGLEPsPPQCDyI
0 5
NCK1 (human) LTSGLEPsPPQCDyI S262-p
NCK1 iso2 (human) LTSGLEPSPPQCDYI S198
NCK1 (mouse) LTSGLEPSPPQCDyI S262
NCK1 (rat) LTSGLEPSPPQCDYI S262
Y268-p
PsPPQCDyIRPSLTG
0 15
NCK1 (human) PsPPQCDyIRPSLTG Y268-p
NCK1 iso2 (human) PSPPQCDYIRPSLTG Y204
NCK1 (mouse) PSPPQCDyIRPSLTG Y268-p
NCK1 (rat) PSPPQCDYIRPSLTG Y268
K286-ub
GNPWYYGkVTRHQAE
0 2
NCK1 (human) GNPWYYGkVTRHQAE K286-ub
NCK1 iso2 (human) GNPWYYGKVTRHQAE K222
NCK1 (mouse) GNPWYYGKVTRHQAE K286
NCK1 (rat) GNPWYYGKVTRHQAE K286
S313-p
LIRDSESsPNDFSVS
0 2
NCK1 (human) LIRDSESsPNDFSVS S313-p
NCK1 iso2 (human) LIRDSESSPNDFSVS S249
NCK1 (mouse) LIRDSESSPNDFSVS S313
NCK1 (rat) LIRDSESSPNDFSVS S313
K322-ub
NDFSVSLkAQGKNKH
0 1
NCK1 (human) NDFSVSLkAQGKNKH K322-ub
NCK1 iso2 (human) NDFSVSLKAQGKNKH K258
NCK1 (mouse) NDFSVSLKAQGKNKH K322
NCK1 (rat) NDFSVSLKAQGKNKH K322
Y339-p
VQLKETVyCIGQRkF
0 18
NCK1 (human) VQLKETVyCIGQRkF Y339-p
NCK1 iso2 (human) VQLKETVYCIGQRKF Y275
NCK1 (mouse) VQLKETVYCIGQRKF Y339
NCK1 (rat) VQLKETVYCIGQRKF Y339
K345-ub
VyCIGQRkFsTMEEL
0 1
NCK1 (human) VyCIGQRkFsTMEEL K345-ub
NCK1 iso2 (human) VYCIGQRKFSTMEEL K281
NCK1 (mouse) VYCIGQRKFstMEEL K345
NCK1 (rat) VYCIGQRKFsTMEEL K345
S347-p
CIGQRkFsTMEELVE
0 5
NCK1 (human) CIGQRkFsTMEELVE S347-p
NCK1 iso2 (human) CIGQRKFSTMEELVE S283
NCK1 (mouse) CIGQRKFstMEELVE S347-p
NCK1 (rat) CIGQRKFsTMEELVE S347-p
T348
IGQRkFsTMEELVEH
0 2
NCK1 (human) IGQRkFsTMEELVEH T348
NCK1 iso2 (human) IGQRKFSTMEELVEH T284
NCK1 (mouse) IGQRKFstMEELVEH T348-p
NCK1 (rat) IGQRKFsTMEELVEH T348
Y356
MEELVEHYkkAPIFT
0 1
NCK1 (human) MEELVEHYkkAPIFT Y356
NCK1 iso2 (human) MEELVEHYKKAPIFT Y292
NCK1 (mouse) MEELVEHYKKAPIFT Y356
NCK1 (rat) MEELVEHyKKAPIFT Y356-p
K357-ub
EELVEHYkkAPIFTS
0 1
NCK1 (human) EELVEHYkkAPIFTS K357-ub
NCK1 iso2 (human) EELVEHYKKAPIFTS K293
NCK1 (mouse) EELVEHYKKAPIFTS K357
NCK1 (rat) EELVEHyKKAPIFTS K357
K358-ub
ELVEHYkkAPIFTSE
0 1
NCK1 (human) ELVEHYkkAPIFTSE K358-ub
NCK1 iso2 (human) ELVEHYKKAPIFTSE K294
NCK1 (mouse) ELVEHYKKAPIFTSE K358
NCK1 (rat) ELVEHyKKAPIFTSE K358
K369-ub
FTSEQGEkLYLVKHL
0 1
NCK1 (human) FTSEQGEkLYLVKHL K369-ub
NCK1 iso2 (human) FTSEQGEKLYLVKHL K305
NCK1 (mouse) FTSEQGEKLyLVKHL K369
NCK1 (rat) FTSEQGEKLYLVKHL K369
Y371
SEQGEkLYLVKHLS_
0 2
NCK1 (human) SEQGEkLYLVKHLS_ Y371
NCK1 iso2 (human) SEQGEKLYLVKHLS_ Y307
NCK1 (mouse) SEQGEKLyLVKHLS_ Y371-p
NCK1 (rat) SEQGEKLYLVKHLS_ Y371